Arcutis Biotherapeutics Inc. (ARQT) Statistics & Valuation Metrics - Stocknear

Arcutis Biotherapeutics I...

NASDAQ: ARQT · Real-Time Price · USD
17.15
0.94 (5.80%)
At close: Sep 05, 2025, 3:59 PM
17.15
0.00%
After-hours: Sep 05, 2025, 07:54 PM EDT

Arcutis Biotherapeutics Statistics

Share Statistics

Arcutis Biotherapeutics has 119.91M shares outstanding. The number of shares has increased by 1.98% in one year.

119.91M
1.98%
0.48%
99.19%
104.51M
6,985
0.4%

Short Selling Information

The latest short interest is 18.4M, so 15.35% of the outstanding shares have been sold short.

18.4M
15.35%
18.96%
8.47

Valuation Ratios

The PE ratio is -12.03 and the forward PE ratio is 115.79. Arcutis Biotherapeutics's PEG ratio is 0.17.

-12.03
115.79
8.57
4.7
10.7
-15
0.17
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Arcutis Biotherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.15, with a Debt / Equity ratio of 0.7.

4.15
3.97
0.7
-1.01
-0.98
-4.73

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$574.68K
$-409.47K
342
0.56
1.32

Taxes

647K
-0.46%

Stock Price Statistics

The stock price has increased by 65.54% in the last 52 weeks. The beta is 1.94, so Arcutis Biotherapeutics's price volatility has been higher than the market average.

1.94
65.54%
15.07
14.08
65.92
1,744,264

Income Statement

In the last 12 months, Arcutis Biotherapeutics had revenue of 196.54M and earned -140.04M in profits. Earnings per share was -1.16.

196.54M
177.41M
-128.4M
-140.04M
-109.63M
-112.22M
-1.16
Full Income Statement

Balance Sheet

The company has 71.33M in cash and 110.58M in debt, giving a net cash position of -39.25M.

71.33M
110.58M
-39.25M
-1.12B
352.43M
228.84M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -112.16M and capital expenditures -143K, giving a free cash flow of -112.3M.

-112.16M
-143K
-112.3M
-0.93
Full Cash Flow Statement

Margins

Gross margin is 90.27%, with operating and profit margins of -65.33% and -71.25%.

90.27%
-65.33%
-70.92%
-71.25%
-55.78%
-65.33%
-57.14%

Dividends & Yields

ARQT does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ARQT is $19, which is 10.8% higher than the current price. The consensus rating is "Buy".

$19
10.8%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

1.44
4